ALLG APML5: Bioavailability and safety of oral arsenic trioxide assessed during consolidation therapy for APL.
Iland HJ, Reynolds J, Boddy A, Schultz HB, Khoo L, Fleming SA, Lane SW, Weber N, Gasiorowski R, Armytage T, Harrup RA, Watson AM, Tan P, Filshie R, Kwok F, Stevenson WS, Yuen SLS, Ng APC, Rowley L, Marlton P, Wei AH.
Iland HJ, et al. Among authors: lane sw.
Blood Adv. 2025 Jan 28:bloodadvances.2024015397. doi: 10.1182/bloodadvances.2024015397. Online ahead of print.
Blood Adv. 2025.
PMID: 39874494